AdvaMed is the leading medtech industry conference in North America. From October 17-19, 2016 Minneapolis will host thousands of medtech industry leaders gathered together in a multifaceted environment for business development, capital formation, technology showcasing, world-class educational opportunities and networking.
GCMI was founded upon, and still operates with, the goal of providing necessary resources and market expertise for innovators, engineers, and physicians wanting to bring novel medical technologies from concept to commercialization.
“GCMI levels the playing field for small medtech startups to get a toe hold, work through regulatory, make it to market and then scale. With their help, we were able to avoid millions of dollars in upfront costs.” – John O’Shaughnessy Founder & CEO, Matrix Surgical USA
Not only is AdvaMed a great opportunity to reconnect with long time partners, innovators and colleagues while meeting new ones, it also generates new knowledge and fresh perspectives on the current landscape influencing medical technology policy and trends. We anticipate AdvaMed 2016 will be ‘business as usual’ at the conference. And that’s good. Here’s what we are particularly looking forward to.
Gaining perspective on the current medtech landscape
Every year the medtech investment environment shifts due to of the FDA’s implementation of new policies. It is always good to hear from industry leaders about how things are changing and what results can be expected. It helps us validate assumptions and better know what startups and innovators in the early stages of medtech development need to position themselves for successful commercialization.
Medtech investment flow + leveraging funding for long-term success
The “Leveraging Non-Dilutive Funding for Long-Term Success” session at 1 pm on Monday will look at how advanced technology and medical devices can best leverage National Institutes of Health (NIH) funding. This session sticks out to us because NIH funding was critical to GCMI’s foundation and our goals are parallel: helping young companies secure funding and resources that can be leveraged for success.
This aligns closely with our participation on the National Advisory Council on Innovation & Entrepreneurship (NACIE). NACIE members have been promoting smart utilization of existing funds provided by organizations, like the NIH, so that medtech startups and their products may develop efficiently improving their ability to generate follow-on investments needed to reach commercialization.
Every year there’s a panel titled “Current Investment Flow, M&A and Deal Structures.” This year it takes place at 4:30 pm on Tuesday, Nov. 15. Given the importance of investment in medtech innovation and the need for greater awareness for the robust nature of the medtech ecosystem in the southeastern United States, his session is always of high interest to the GCMI team.
Let’s connect at Advamed 2016
For medtech innovators seeking to bring novel technologies and therapies to life – concept to cure to commercialization – let’s connect! Contact GCMI to set up a meeting during AdvaMed 2016! You can find the full conference program here.